The effectiveness of Zhi-Shi plaster acupoint therapy combined with lactulose in the treatment of geriatrics functional constipation: a randomized controlled trial

知氏贴剂穴位疗法联合乳果糖治疗老年功能性便秘的疗效:一项随机对照试验

阅读:1

Abstract

OBJECTIVE: This study aimed to evaluate the effectiveness and adverse effects of Zhi-Shi plaster acupoint therapy combined with Lactulose in the Treatment of geriatrics Functional Constipation. METHODS: A total of 62 geriatrics Functional Constipation patients were randomly assigned to the intervention group (n = 31) and control group (n = 31). The intervention group received oral lactulose (20 mL daily for 14 consecutive days) plus Zhi-Shi plaster acupoint therapy (for 4 h daily at the following acupoints: CV8, bilateral ST25, and bilateral SP15). The control group received oral lactulose plus placebo acupoint therapy during the same period. The primary outcomes included the clinical efficacy and the Constipation Symptom Scoring Scale (CSS). Secondary outcomes included the weekly count of complete spontaneous bowel movements (CSBMs), the Bristol Stool Form Scale (BSFS), the Patient Assessment of Constipation-Symptoms (PAC-SYM), the Constipation Quality of Life Scale (PAC-QOL), and adverse effects. Assessments were conducted at baseline, the week1, the week2, and the week6, with data analysis using generalized estimating equations. And the outcome assessors and statistician was blinded. RESULTS: After treatment, the overall clinical efficacy was higher in the intervention group than in controls (96.77% vs. 83.87%, p = 0.03). The intervention group demonstrated superior improvements across outcomes compared to the control group: constipation symptoms (CSS: coefficient = -3.36, 95% CI: -4.68 to -2.03, p < 0.001), frequency of complete spontaneous bowel movements (CSBMs: coefficient = 0.59, 95% CI: 0.40 to 0.79, p < 0.001), and stool consistency (BSFS: coefficient = 0.45, 95% CI: 0.20 to 0.70, p < 0.001). Similarly, significant reductions in patient-assessed symptom severity (PAC-SYM: coefficient = -0.72, 95% CI: -0.91 to -0.52, p < 0.001) and greater enhancements in quality of life (PAC-QOL: coefficient = -0.34, 95% CI: -0.43 to -0.24, p < 0.001) were observed. Finally, the incidence of adverse reactions was lower in the intervention group (3.22% vs. 19.35%, p = 0.015). CONCLUSION: The combination of lactulose and Zhi-Shi plaster acupoint therapy for the treatment of geriatrics Functional constipation can significantly improve clinical efficacy, reduce adverse effects, alleviate symptoms and enhance quality of life. CLINICAL TRIAL REGISTRY: This trial was registered in the International Traditional Medicine Clinical Trial Registry (ITMCTR; registration number: ITMCTR2024000401).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。